L-Seryl-L-phenylalanyl-L-leucyl-L-leucyl-L-arginyl-L-asparagine

L-Seryl-L-phenylalanyl-L-leucyl-L-leucyl-L-arginyl-L-asparagine forms a hexapeptide combining hydrophobic, aromatic, and charged residues. The sequence supports studies of β-turn formation, hydrophobic clustering, and protein-binding motifs. Researchers use it to evaluate folding transitions and solvent effects. Its balanced composition enables robust structural analysis.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
L-Seryl-L-phenylalanyl-L-leucyl-L-leucyl-L-arginyl-L-asparagine(CAS 141136-83-6)

CAT No: R2227

CAS No:141136-83-6

Synonyms/Alias:TRAP-6;141136-83-6;Thrombin Receptor Activator Peptide 6;L-Seryl-L-phenylalanyl-L-leucyl-L-leucyl-L-arginyl-L-asparagine;Ser-Phe-Leu-Leu-Arg-Asn;MFCD00238172;SFLLRN;(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-oxobutanoic acid;(2S,5S,8S,11S,14S,17S)-17-Amino-2-(2-amino-2-oxoethyl)-14-benzyl-5-(3-guanidinopropyl)-18-hydroxy-8,11-diisobutyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazaoctadecan-1-oic acid;PAR1 agonist;SFLLRN-OH;PAR-1 agonist peptide;TRAP 6;Thrombin Receptor (1-6);PAR-1 agonist peptide;Thrombin Receptor Activator Peptide 6;TRAP-6?;CHEMBL78392;SCHEMBL15929733;BDBM85086;DTXSID90431405;HAGOWCONESKMDW-FRSCJGFNSA-N;HY-P0078;AKOS024457641;CS-5508;Coagulation Factor II Receptor (1-6);NCGC00167239-01;AC-32572;AS-71526;DA-78586;C72622;Thrombin Receptor Activator Peptide 6, >95% (HPLC);L-Asparagine,l-seryl-L-phenylalanyl-L-Leucyl-L-leucyl-l-arginyl-;(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-phenylpropanamido]-4-methylpentanamido]-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-carbamoylpropanoic acid;(2S,5S,8S,11S,14S,17S)-17-Amino-2-(2-amino-2-oxoethyl)-14-benzyl-5-(3-guanidinopropyl)-18-hydroxy-8,11-diisobutyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazaoctadecan-1-oicacid;141136-83-6, TRAP 6, Thrombin Receptor Activator Peptide 6, PAR1 agonist, Thrombin Receptor (1-6), Coagulation Factor II Receptor (1-6);

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C34H56N10O9
M.W/Mr.
748.9
Sequence
One Letter Code:SFLLRN
Three Letter Code:H-Ser-Phe-Leu-Leu-Arg-Asn-OH
InChI
InChI=1S/C34H56N10O9/c1-18(2)13-23(30(49)40-22(11-8-12-39-34(37)38)29(48)44-26(33(52)53)16-27(36)46)42-31(50)24(14-19(3)4)43-32(51)25(41-28(47)21(35)17-45)15-20-9-6-5-7-10-20/h5-7,9-10,18-19,21-26,45H,8,11-17,35H2,1-4H3,(H2,36,46)(H,40,49)(H,41,47)(H,42,50)(H,43,51)(H,44,48)(H,52,53)(H4,37,38,39)/t21-,22-,23-,24-,25-,26-/m0/s1
InChI Key
HAGOWCONESKMDW-FRSCJGFNSA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Synthesis ServicesPeptide CDMOCustom Conjugation ServicePeptide Analysis ServicesPeptide Modification ServicescGMP Peptide ServicePeptide Nucleic Acids SynthesisEpitope Mapping Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers